Good morning :)
Place Order
Add to Watchlist

Procter & Gamble Health Ltd

PGHL

Procter & Gamble Health Ltd

PGHL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,433 cr, stock is ranked 524
Moderate RiskStock is 2.09x as volatile as Nifty
5,080.400.21% (-10.90)
5,080.400.21% (-10.90)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,433 cr, stock is ranked 524
Moderate RiskStock is 2.09x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,433 cr, stock is ranked 524
Moderate RiskStock is 2.09x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
37.2111.231.21%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
52.466.010.56%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -5.05%, vs industry avg of 8.36%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.8% to 0.38%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -22.83%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue962.811,016.97772.071,616.921,424.751,026.831,127.601,248.011,258.66
Raw Materialssubtract436.87413.32222.95272.83444.47310.39344.55358.99921.69
Power & Fuel Costsubtract15.1414.9611.6812.2319.0912.9714.7012.88
Employee Costsubtract123.17154.23109.88131.27182.93153.66167.56206.17
Selling & Administrative Expensessubtract226.39237.59188.49192.98257.28173.99203.91196.86
Operating & Other expensessubtract54.4956.8988.1691.53136.68111.70116.01130.04
Depreciation/Amortizationsubtract23.4224.8119.1221.1229.4530.0427.0828.1025.79
Interest & Other Itemssubtract0.000.000.000.000.000.800.420.770.75
Taxes & Other Itemssubtract29.7736.0437.8856.24100.7756.4860.8584.7383.78
EPS32.2747.6756.57505.27153.07106.51115.98138.24136.54
DPS7.5011.0015.00440.00230.00130.0052.5061.5095.00
Payout ratio0.230.230.270.871.501.220.450.440.70

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Procter & Gamble Health Ltd36.7511.231.21%
Sun Pharmaceutical Industries Ltd44.826.400.73%
Cipla Ltd42.865.060.57%
Dr Reddy's Laboratories Ltd23.834.610.62%

Price Comparison

Compare PGHL with any stock or ETF
Compare PGHL with any stock or ETF
PGHL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.82%8.98%3.68%7.59%27.92%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '236.05%6.33%6.72%7.15%7.38%7.59%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Procter & Gamble Health Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH

Growth
4.0148%0.74%-0.01%107/217 (-3)
HDFC Small Cap Fund - Direct Plan - Growth Option

Growth
1.9849%0.59%-0.07%56/76 (0)
UTI AMC LTD # UTI MF-UTI MNC FUND DIRECT PLAN GROWTH PLAN GROWTH

Growth
1.0628%3.29%0.46%11/44 (+1)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateFeb 14, 2024

Interim
Interim | Div/Share: ₹50.00

Dividend/Share

50.00

Ex DateEx Date

Feb 14, 2024

Cash Dividend

Ex DateEx DateFeb 14, 2024

Special
Special | Div/Share: ₹150.00

Dividend/Share

150.00

Ex DateEx Date

Feb 14, 2024

Cash Dividend

Ex DateEx DateNov 23, 2023

Final
Final | Div/Share: ₹50.00

Dividend/Share

50.00

Ex DateEx Date

Nov 23, 2023

Cash Dividend

Ex DateEx DateFeb 13, 2023

Interim
Interim | Div/Share: ₹45.00

Dividend/Share

45.00

Ex DateEx Date

Feb 13, 2023

Cash Dividend

Ex DateEx DateNov 15, 2022

Final
Final | Div/Share: ₹11.50

Dividend/Share

11.50

Ex DateEx Date

Nov 15, 2022